Skip to content
SentinelMarket desk
Switch to dark mode

테고사이언스

191420KOSDAQView the 제약 sectorTheme Bio & healthcare

6,710KRWMarket close of 10/21 (Wed)

Down -1.90%-130KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)7,020KRWUp +4.62%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
6,690
High
6,870
Low
6,610
Day range
Day range low 6,610 high 6,870, open 6,690, close 6,710, previous close 6,840
Volume
0×10K shares
18.94 million KRW 0.43× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 5,600 to 18,400 won, 9% up from the low

9% of the way up from the lowest close in 1 year (252 sessions) · -63.5% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-5.4B KRWOperating income over the last four quarters -5.4B KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-1.90%usual range
  • Trading value0.4×usual range
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue1.2B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -8.7%
    vs. prior quarter
    -14.0%
  • Operating income-1.9B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss
  • Operating margin-155.8%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -88.1 pp
    vs. prior quarter
    -3.6 pp

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-06-25
2021Q1 -796.29 million KRW2026Q1 -1.9B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.